SRX Health Solutions Inc. Announces Fiscal First Quarter 2026 Results for Quarter Ended December 31, 2025

Executed Definitive Agreement to Acquire EMJ Crypto Technologies (“EMJX”), a “Gen 2” Digital-Asset Treasury Platform, Anticipated to Close in first half of Calendar 2026 

Strengthened Balance Sheet, with $13.1 Million in Cash at Quarter End

During and Subsequent to Quarter, Deployed $18 Million Into Bitcoin and Ethereum as part of Digital Treasury Strategy

NORTH PALM BEACH, Fla., Feb. 13, 2026 (GLOBE NEWSWIRE) — SRx Health Solutions, Inc. (NYSE:SRXH) (the “Company” or “SRXH“), a pet health and wellness company, today announced its financial results for the fiscal first quarter 2026 for the three-month period ended December 31, 2025.

“Q1 FY26 marked a pivotal reset for the Company,” stated Kent Cunningham, CEO of SRXH. “We exited prior balance sheet restructuring with materially improved liquidity and a stronger capital foundation. Funding constraints leading into the quarter temporarily reduced inventory levels and resulted in below-normal fill rates, which constrained sales of our U.S. pet wellness brand, Halo^®. Underlying consumer demand remained resilient, and at normalized inventory levels we would have delivered year-over-year growth. Despite limited marketing investment, we maintained our presence across core digital channels and expanded gross margin to 38% through disciplined SKU rationalization and a stronger product mix, including the proactive exit of tariff-impacted products ahead of calendar 2026. With additional capital raised subsequent to quarter-end and deployed strategically to support operational priorities and our digital treasury strategy, we are restoring momentum and positioning the business for a stronger and more profitable 2026.”

“During the quarter, we improved our balance sheet and announced a definitive agreement to acquire EMJ Crypto Technologies, which will advance a broader strategic shift toward multi-asset digital treasury management. To date, we have deployed $18 million into cryptocurrency, including Bitcoin and Ethereum. We look forward to closing on EMJX during the current calendar first quarter and unlocking long-term value for shareholders,” stated Michael Young, Board Member of SRx Health.

FIRST QUARTER 2026 HIGHLIGHTS

• EMJX Definitive Agreement: Entered into a definitive agreement to acquire EMJX, a digital-asset treasury platform integrating quantitative models, artificial intelligence, and systematic risk controls for multi-asset digital treasury management, led by Eric M. Jackson.
• Digital Treasury Deployment: Deployed an initial $8.5 million of capital into several digital assets during the quarter; subsequent purchases increased total allocation to $18.0 million across Bitcoin and Ethereum.
• Operating Results: Net sales of $2.8 million, driven primarily by digital sales of premium pet food and wellness products under the Halo^® brand; Gross margin improved to 38%, with gross profit of $1.1 million; Net loss of $8.6 million includes $3.1 million non-cash loss on debt extinguishment; Adjusted EBITDA loss of $1.06 million¹; Diluted loss per share of $(0.26).

LIQUIDITY AND CAPITAL RESOURCES

As of December 31, 2025, the Company held cash and cash equivalents of $13.1 million, compared to $1.3 million at September 30, 2025.

The major sources of cash in the three months ended December 31, 2025 were primarily proceeds from the issuance of common stock of $16.1 million and preferred stock of $8.9 million, partially offset by $8.5 million deployed into digital assets and $1.6 million used to repay and settle convertible debt.